Affimed NV
NASDAQ:AFMD

Watchlist Manager
Affimed NV Logo
Affimed NV
NASDAQ:AFMD
Watchlist
Price: 0.96 USD -12.73% Market Closed
Market Cap: 14.6m USD

Wall Street
Price Targets

AFMD Price Targets Summary
Affimed NV

There are no price targets for AFMD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Affimed NV Competitors:
Price Targets
TIL
Instil Bio Inc
701% Upside
MCRB
Seres Therapeutics Inc
59% Downside
BIOPOR
Bioporto A/S
158% Upside
DSGN
Design Therapeutics Inc
61% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
48% Downside
300896
Imeik Technology Development Co Ltd
37% Upside
CPRX
Catalyst Pharmaceuticals Inc
40% Upside
BSLN
Basilea Pharmaceutica AG
101% Upside

Revenue
Forecast

Revenue Estimate
Affimed NV

For the last 8 years the compound annual growth rate for Affimed NV's revenue is 1%. The projected CAGR for the next 4 years is 14%.

1%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Affimed NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Affimed NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-57%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AFMD's stock price target?
Not Available

AFMD doesn't have any price targets made by Wall Street professionals.

What is Affimed NV's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Affimed NV's revenue is 1%. The projected CAGR for the next 4 years is 14%.

Back to Top